Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin in MAC Lung Disease
NCT00599079Phase 4Completed
- Sponsor
- The University of Texas Health Science Center at Tyler
- Start
- Feb 1993
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of azithromycin in Mycobacterium avium complex lung disease, Mycobacterium abscessus lung disease, sponsored by The University of Texas Health Science Center at Tyler. Started Feb 1993; status: completed.
02
Drugs
azithromycin
03
Conditions
Mycobacterium avium complex lung diseaseMycobacterium abscessus lung disease
Beyond the preview
Go deeper on NCT00599079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00599079.